PH 5.1 communicate with patient on all aspects of drug use
PH 5.2 Communicate with patient on proper use of drug /delivery device & storage of medicine PH 5.3 Communicate the patient to motivate adherence to treatment in chronic diseases PH 5.5 Communicate with patient regarding cost of treatment
a beautiful ppt, illustrating the principles for prescribing, current concepts for clinical decision making, for practicing medicine and health care planning worldwide...
Medication Error are the most preventable events and Clinical Pharmacists can play a vital role in preventing them. in this presentation i have tried to provide maximum information regarding medication error in minimum slides.
Medication Reconciliation A Basic OverviewAnupam Das
Hi everyone, in this presentation I have shared a basic overview of Medication Reconciliation and its benefits & challenges.
However, this is for education & information purpose only.
PH 5.1 communicate with patient on all aspects of drug use
PH 5.2 Communicate with patient on proper use of drug /delivery device & storage of medicine PH 5.3 Communicate the patient to motivate adherence to treatment in chronic diseases PH 5.5 Communicate with patient regarding cost of treatment
a beautiful ppt, illustrating the principles for prescribing, current concepts for clinical decision making, for practicing medicine and health care planning worldwide...
Medication Error are the most preventable events and Clinical Pharmacists can play a vital role in preventing them. in this presentation i have tried to provide maximum information regarding medication error in minimum slides.
Medication Reconciliation A Basic OverviewAnupam Das
Hi everyone, in this presentation I have shared a basic overview of Medication Reconciliation and its benefits & challenges.
However, this is for education & information purpose only.
It covered all topics from syllabus of prescription chapter
of pharmaceutics-2,
It's become helpfull for diploma students, took all topics from R.M.Mehta pharmaceutics-2, 3rd edition-2010, vallabh prakashan.
HAP/VAP 2016 ATS/IDSA Guidelines. Our Data available at: https://rdcu.be/Mx8EDr Sandeep Kumar
Management of Adults With Hospital-acquired and
Ventilator-associated Pneumonia: 2016 Clinical Practice
Guidelines by the Infectious Diseases Society of America
and the American Thoracic Society.
To see our study results on HCAP and HAP, VISIT https://link.springer.com/article/10.1007/s00408-018-0117-7
Mutations in Chronic myeloid leukaemia and Imatinib resistanceDr Sandeep Kumar
some corrections over previous presentation on CML. Covers topics like - pathophysiology of CML, Mutations discussed in detail, TKI resistance in various mutations and treatment options. Also Imatinib resistance has been discussed in detail.
detailed discussion on cytogenetics in CML - Pathophysiology, treatment, TKI Resistance, Mutation analysis timing, various mutations in CML, BCR-ABL1 Variants, Significance of mutations and management.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
2. As someone said, “I worried so much about
prescription writing in my 3rd Year of Med school, I
probably killed a whole tree tearing up
Prescriptions that were wrong.”
- medschoolhq.net
3. The eye of Horus. Attribution: By Jon Bodsworth [Copyrighted free use
via Wikimedia Commons. https://commons.wikimedia.org/wiki/File:
Wedjat_(Udjat)_Eye_of_Horus_pendant.jpg
4. In ancient Egypt, this symbol was written on
prescriptions as a prayer to the God of
healing.
Rx is also a symbol for the Eye of Horus.
Horus was an Egyptian God who had his eye
damaged and taken out of him. He had his
eye healed by another god and Horus then
gave his healed eye to his dead father to bring
him back to life.
In the days of mythology and superstition,
the symbol was considered as a prayer to
Jupiter, the God of healing, for the quick
recovery of the patient.
In Latin, it means “recipe” or “take thou,”
that is, “you take””
5. Definition Written, Verbal,
or Electronic
order
Registered
Medical
Practitioner
Pharmacist
Particular
Medication
Particular
Patient
6.
7. Poorly written prescriptions may be one of the main reasons there are so many medication
errors today. Look at some of these commonly quoted statistics:
Medication errors occur in approximately 1 in every 5 doses given in hospitals.
One error occurs per patient per day.
8. Approximately 1.3 million injuries and 7,000 deaths occur each year in the U.S. from
medication-related errors.
Drug-related morbidity and mortality are estimated to cost $177 billion in the U.S.
It is the eighth leading cause of death in the United States with more than 98,000 people
dying because of it annually.
9. The National Patient Safety Agency revealed that medication errors in all care settings in the
United Kingdom occurred in each stage of the medication treatment process, with
16% errors occurring in the prescribing,
18% in the dispensing, and
50% in the administration of drugs.
In India, studies done in Uttarakhand and Karnataka have documented the medication errors
rate in hospitalized patients to be as high as 25.7% and 15.34%, respectively.
10. HOW TO WRITE A
PRESCRIPTION IN 4 PARTS
Patient’s name and another identifier, usually date of birth.
Medication and strength, amount to be taken, route by which it is
to be taken, and frequency.
Amount to be given at the pharmacy and number of refills.
Signature and physician identifiers like NPI or DEA numbers.
11.
12. PRESCRIBER'S DETAILS
It consists of the
1.Name,
2.Address,
3.Registration number, and
4.Contact number of the treating doctor.
The importance of having the prescriber's details on the
prescription is for the benefit of the patient:
a.To contact the doctor in case of emergency or adverse drug
reaction
b.The registration number of the doctor is clearly written and is
an assurance for the patient that the prescriber is registered
with a medical council. This reflects the authenticity of the
13. Prescribers must write clearly, in indelible black pen. Each individual letter must be legible.
All prescriptions must be signed and dated by the prescriber with bleep number/ contact details
and Medical Council Registration No. (use of an individual name stamp is recommended).
Prescribers are expected to adopt a concordant approach to prescribing and keep the patient
informed about proposed changes to their prescription (wherever possible).
Prescribers MUST ensure they are familiar with the drug they are prescribing including
indication, cautions, contraindications, doses, monitoring and drug interactions. It is not
acceptable to ‘copy’ drugs without considering their safety for the patient.
Nurses must be made aware of changes to inpatient prescriptions.
Prescribers must only prescribe for patients registered with the hospital – not staff, visitors or
relatives
14. According to the Joint Commission on Accreditation of Healthcare Organizations (JCAHO)
national patient safety goals:
at least two patient identifiers should be used in various clinical situations.
The two most common patient identifiers are their
Full name and
Date of birth.
Patient identifiers are the first things to write on a prescription. This way you don’t write a
signed prescription without a patient name on it that accidentally falls out of your white coat
and onto the floor in the cafeteria.
15. Patient’s first name and family name.
Date of Birth.
Address.
Patient’s MRD and/or hospital number.
Ward name, or name of department/specialty, and hospital site.
Name of consultant responsible for the patient
16.
17. GENERIC VS. BRAND
The brand name of a medication is the name given by the company that
makes the drug and is usually easy to say for sales and marketing purposes.
The generic name, on the other hand, is the name of the active ingredient.
The key to understand is, though the generic name exists, the company who
developed the drug, through its patents, receives an exclusivity period where
it has the only rights to sell the medication under either the brand or generic
name.
During the period of patent protection, the company sets the price to a point
where it can recover research and development costs along with other cost,
like marketing, while trying to make a profit.
18.
19. It contains the
names and
quantities of the prescribed medicines.
Physicians are supposed to write the
generic name of the drug prescribed by them,
its dose,
frequency, and
the duration of therapy.
This part of prescription is the most important area where the physician has to be very
careful and vigilant. His knowledge about the medicines and his competence is
reflected by what and how he writes
20. You can write the generic or the brand name here unless
you specifically want to prescribe the brand name.
If you do want to prescribe the brand name only, you
specifically need to indicate, “no generics.”
On the prescription pad, there is a small box which can be
checked to indicate “brand name only” or “no generics.”
21. After you write the medication name, you need to tell the pharmacist the desired
strength.
Many, if not most, medications come in multiple strengths. You need to write
which one you want.
Often times, the exact strength you want is not available, so the pharmacist will
substitute an appropriate alternative for you.
For example, if you write prednisone (a corticosteroid) 50 mg, and the pharmacy
only carries 10 mg tablets, the pharmacist will dispense the 10 mg tabs and adjust
the amount the patient should take by a multiple of 5.
22. Using the previous example for prednisone,
the original prescription was for 50 mg tabs. So you would have written,
“prednisone 50 mg, one tab….” (I’ll leave out the rest until we get there). The “one
tab” is the amount of the specific medication and strength to take.
Again using my previous example, due to the 50 mg tabs not being available, the
instructions would be rewritten by the pharmacist as “prednisone 10 mg, five
tabs….” You can see that “one tab” is now “five.” Pharmacists make these changes
all the time, often without any input from the physician.
23. To reduce the number of medication errors, prescription writing should be 100% English,
with no Latin abbreviations.
There are several routes by which a medication can be taken.
The abbreviations are either from Latin roots like PO (“per os”) or just common combination
of letters from the English word. For example, intranasal is often abbreviated “IN,” which, if
you write sloppily, can be mistaken for “IM” or “IV.”
All other routes of administration must be written out in full, e.g. intrathecal, epidural,
sublingual, buccal.
Prescribers must specify the precise location or area to be covered for topical drugs.
24. IV – intravenous
PV – vaginally
SC – subcutaneous
JEJ – via jejunostomy tube
IM – intramuscular
INH – inhalation
NEB – nebulised
PEG – via percutaneous endoscopic gastrostomy tube
PO – oral
NG – nasogastric
TOP – topical
PR – rectal
PV – vaginal
26. Frequency = How often you want the patient to take the medication.
Many frequencies start with the letter “q.”
This Q is from the Latin word quaque, which means once.
So in the past, if you wanted a medication to be taken once daily, you would write
QD, for “once daily” (“d” is from “die,” the Latin word for day).
However, to help reduce medication errors, QD and QOD (every other day) are on
the JCAHO “do not use” list.
So you need to write out “daily” or “every other day.”
27. Many prescriptions that you write will be for “as needed” medications.
This is known as “PRN,” from the Latin pro re nata,
meaning “as circumstances may require.”
For example, you may write for Ibuprofen every 4 hours “as needed.”
What physicians and medical students commonly miss with PRN medications is the
“reason.”
Why would it be needed?
You need to add this to the prescription. You should write “PRN headache” or “PRN
pain,” so the patient knows when to take it.
For example, you may write for Paracetamol 650 mg “as needed for Fever.”
28. The “how much” instruction tells the pharmacist
how many pills
how many bottles, or
how many inhalers.
Typically, you write the number after “Disp #.”
Spell out the number after the # sign, even though this is not required.
For example, I would write “Disp #30 (thirty).”
This prevents someone from tampering with the prescription and adding an extra 0 after 30,
turning 30 into 300, e.g. drug addicts.
29. The last instruction on the prescription informs the pharmacist how many times
the patient can use the same exact prescription, i.e. how many refills they can get.
For example, let’s take refills for anti-anxiety medications for a patient.
A physician may prescribe 1 pack [10 Tablets] of a BZDs with 1 refills, which
would last the patient, three weeks.
This is convenient for both the patient and physician for any medications that will
be used long term.
30. Prescriber’s signature
Date
Refill instructions
Generic/Brand substitution instructions
The onus lies on the prescriber for being responsible for the facts
mentioned in the prescription.
Hence, it is important to safeguard one's interest; the prescriber
should be well acquainted with the art of writing a prescription.
There is no margin for any error as a prescription directly deals with
the patient's well-being and life.
5
31. All details must be completed in the prescriber’s handwriting. The following details are
required:
Name and address of patient (an addressograph with the prescriber’s initials can be
used).
Name of drug
Form of drug e.g. MR tablet. Check what form the preparation is available in.
Strength.
Dose the patient is to take, including frequency.
Total quantity of the preparation or the number of dose units – in both words and
figures (except inpatient medication charts).
Prescribers signature, registration number and contact details
32. U or u (unit) – use “Unit”
IU (International unit) – use “International Unit”
Q.D./QD/q.d./qd – use “daily”
Q.O.D./QOD/q.o.d./qod – use “every other day”
Trailing zeros (#.0 mg) – use # mg
Lack of leading zero (.#) – use 0.# mg
MS – use “morphine sulfate” or “magnesium sulfate”
MS04 and MgSO4 – use “morphine sulfate” or “magnesium sulfate”
33.
34. Define the patient’s problem
Make a specific diagnosis
Consider the pathophysiologic implications of the Diagnosis
Define the therapeutic objective
Select a Drug of Choice [Efficacy, Safety, Suitability, Cost]
Write the drug with the appropriate dosing regimen
Start the treatment and discuss adverse effects or warnings, instructions and give information
Monitor the therapy and give advice on follow up
42. Inadequate knowledge of the patient and their clinical status
Inadequate drug knowledge
Calculation errors
Illegible handwriting
Drug name confusion {LASA}
poor history taking
Fatigue and workload may also contribute to the risk of slips and lapses.
43.
44.
45. ALWAYS write legibly.
ALWAYS space out words and numbers to avoid confusion.
ALWAYS complete medication orders.
AVOID abbreviations.
When in doubt, ask to verify.
46.
47.
48.
49. a. the patient’s full name, address, date of birth and hospital/health record number on the
front page together with the ward and consultant’s name, either written directly or by
affixing an addressograph label.
b. the patient’s name and health record number should be visible on each subsequent
page of the chart to reduce the risk of prescribing and administration error.
c. recording the date of admission of the patient to hospital on the front page.
d. where relevant, the recording of hospital site.
50. a. a box for drug allergies and sensitivities [a single box using both descriptors] in a
prominent place on the front page, preferably in a different eye-catching colour and
with sufficient space to describe any previous reaction(s).
b. space to document a finding of no known allergies/sensitivities
c. a clear, bold statement that allergies/sensitivities recording must be documented
before prescription/administration except in exceptional circumstances.
d. space for the name and designation of the person recording the drug
allergy/sensitivity history.
51. 3. There should be a box of sufficient size to allow the recording of dose units
written in full e.g. micrograms, units etc for each item.
4. There should be a box for additional information for each item e.g. duration,
review date, special use, monitoring requirements.
5. There should be boxes to add details of the patient’s age, height, weight (with
date of measurement) and body surface area. The mandatory completion of these
boxes will be a matter for local policy.
6. There should be space for the inclusion of a statement that venous
thromboembolism risk assessment has been undertaken.
53. Good prescribing practice:
Where a patient is known to have a
specific
reaction to a medicine;
- record the reaction clearly,
- sign and date your entry.
Where the patient is thought to have an
allergy or reaction to a medicine but the
type of reaction is not known write
‘Unknown’ sign and date the entry.
Remember: Update the allergy status
should any new reactions occur.
54. Dedicated page for Antibiotics
Notice how different
components of
Prescription writing are
used in this section